Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Substance Use and Sleep Problems in Patients With Psychotic Disorders

Cederlöf Erik; Holm Minna; Ahti Johan; Lähteenvuo Markku; Hietala Jarmo; Häkkinen Katja; Isometsä Erkki; Kampman Olli; Lahdensuo Kaisla; Lönnqvist Jouko; Suvisaari Jaana; Tiihonen Jari; Wegelius Asko; Veijola Juha; Palotie Aarno; Kieseppä Tuula; Niemelä Solja; Paunio Tiina

Substance Use and Sleep Problems in Patients With Psychotic Disorders

Cederlöf Erik
Holm Minna
Ahti Johan
Lähteenvuo Markku
Hietala Jarmo
Häkkinen Katja
Isometsä Erkki
Kampman Olli
Lahdensuo Kaisla
Lönnqvist Jouko
Suvisaari Jaana
Tiihonen Jari
Wegelius Asko
Veijola Juha
Palotie Aarno
Kieseppä Tuula
Niemelä Solja
Paunio Tiina
Katso/Avaa
sgac073.pdf (290.0Kb)
Lataukset: 

Oxford University Press
doi:10.1093/schizbullopen/sgac073
URI
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85160058786&origin=inward
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2025082788743
Tiivistelmä

Background
Substance use and sleep problems are common in patients with psychotic disorders, but their associations in these patients have not been evaluated. We aimed to investigate associations between substance use and sleep problems in a large nationwide cohort of patients with a psychotic disorder.

Study Design
This study is part of the Finnish SUPER study, which belongs to the Stanley Global Neuropsychiatric Genomics Initiative. In this cross-sectional, multicenter study, participants (N = 8616) were recruited from primary and specialized healthcare. Patients with schizophrenia, schizoaffective disorder, bipolar disorder, and psychotic depression were included. Information on current alcohol (Alcohol Use Disorders Identification Test-Concise) and cigarette use as well as on lifetime illicit drug use, including cannabis, benzodiazepines, amphetamines, and opioids, was collected using questionnaires. The sleep outcomes in our logistic regression analysis were short (≤6 h) and long sleep (≥10 h) duration, difficulties initiating asleep, early morning awakenings, fatigue, and poor sleep quality (SQ).

Results
Self-reported substance use was associated with a higher prevalence of sleep problems. After adjustments with age, gender, diagnostic group, and living status, hazardous alcohol use (eg, poor SQ odds ratio [OR] = 1.80, 95% CI: 1.49 to 2.16, P < .001), current smoking (short sleep duration OR = 1.28, 95% CI: 1.08 to 1.52, P = .005), and lifetime benzodiazepine misuse (difficulties initiating sleep OR = 2.00, 95% CI: 1.55 to 2.48, P < .001) were associated with sleep problems.

Conclusions
Substance use was associated with sleep problems. Our findings underline the potential benefits of screening substance use when treating sleep problems in patients with psychotic disorders.

Kokoelmat
  • Rinnakkaistallenteet [27094]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste